Last reviewed · How we verify
Topical antihistamine and vasoconstrictor — Competitive Intelligence Brief
phase 3
Topical antihistamine and vasoconstrictor
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Topical antihistamine and vasoconstrictor (Topical antihistamine and vasoconstrictor) — Khon Kaen University. Topical antihistamines and vasoconstrictors work by reducing itching and swelling caused by allergic reactions, and constricting blood vessels to reduce redness and inflammation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Topical antihistamine and vasoconstrictor TARGET | Topical antihistamine and vasoconstrictor | Khon Kaen University | phase 3 | Topical antihistamine and vasoconstrictor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Topical antihistamine and vasoconstrictor class)
- Khon Kaen University · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Topical antihistamine and vasoconstrictor CI watch — RSS
- Topical antihistamine and vasoconstrictor CI watch — Atom
- Topical antihistamine and vasoconstrictor CI watch — JSON
- Topical antihistamine and vasoconstrictor alone — RSS
- Whole Topical antihistamine and vasoconstrictor class — RSS
Cite this brief
Drug Landscape (2026). Topical antihistamine and vasoconstrictor — Competitive Intelligence Brief. https://druglandscape.com/ci/topical-antihistamine-and-vasoconstrictor. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab